Mason Michael 4
4 · Karyopharm Therapeutics Inc. · Filed Mar 1, 2023
Insider Transaction Report
Form 4
Mason Michael
SVP, CFO & Treasurer
Transactions
- Sale
Common Stock
2023-02-27$3.04/sh−2,802$8,509→ 161,566 total
Footnotes (1)
- [F1]This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person.